Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Net Cash Flow (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Net Cash Flow came in at $21.9 million in Q2 2026, up 188.66% on a YoY basis from $7.6 million in Q2 2025, and up 187.6% quarter-over-quarter from -$25.0 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Net Cash Flow (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Net Cash Flow for 5 consecutive years, with $21.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Cash Flow rose 188.66% year-over-year to $21.9 million; the trailing twelve-month figure through Jun 2026 stood at $92.9 million (up 288.06% YoY), and the FY2025 full-year result was $51.6 million, up 210.84% from the prior year.
  • Net Cash Flow advanced to $21.9 million in Q2 2026 per FTRE's latest filing, from -$25.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $50.1 million in Q3 2025 and bottomed at -$25.0 million in Q1 2026.
  • Historically, Net Cash Flow has averaged $4.8 million across 5 years, with a median of $450000.0 in 2022.
  • The widest YoY moves for Net Cash Flow: up 1047.06% in 2024, down 690.32% in 2024.
  • Over 5 years, Net Cash Flow stood at -$800000.0 in 2022, then surged by 312.5% to $1.7 million in 2023, then jumped by 1047.06% to $19.5 million in 2024, then jumped by 135.38% to $45.9 million in 2025, then sank by 52.29% to $21.9 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered $21.9 million, -$25.0 million, and $45.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn -37.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -150.21 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 43.16 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 164.82 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn 21.90 Mn
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -16.70 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -2.26 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn 7.85 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn - -3.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.90 Mn
Mar 31, 2026 -25.00 Mn
Dec 31, 2025 45.90 Mn
Sep 30, 2025 50.10 Mn
Jun 30, 2025 -24.70 Mn
Mar 31, 2025 -19.70 Mn
Dec 31, 2024 19.50 Mn
Sep 30, 2024 -24.50 Mn
Jun 30, 2024 35.10 Mn
Mar 31, 2024 -13.50 Mn
Dec 31, 2023 1.70 Mn
Sep 30, 2023 -3.10 Mn
Jun 30, 2023 -9.10 Mn
Mar 31, 2023 6.30 Mn
Dec 31, 2022 -800,000.00
Sep 30, 2022 17.50 Mn